What happened with CLBT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Cellebrite DI Ltd. helps investigators turn data from phones, computers and cloud applications into usable evidence. Its Inseyets software accesses and extracts encrypted, deleted or hidden data for legally sanctioned investigations. Pathfinder helps investigators analyze evidence, while Guardian products help them manage and share it. Customers generally run the software on their own systems, though some offerings are available online.
Government agencies, especially law enforcement, supply the vast majority of revenue; corporations and service providers make up a smaller business. Customers mainly pay through annual or multi-year software subscriptions, with updates and technical support included in on-premise subscription offerings. Expansion has relied chiefly on existing customers buying additional subscriptions, making renewals, broader adoption and government funding central to the business.
Cellebrite must keep its device-access capabilities working as manufacturers change security, encryption and operating systems. Israeli export controls and other countries’ licensing and sanctions rules also limit where it can supply some products and when it needs government permission.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Cellebrite’s results hinge on law-enforcement spending on digital forensics and competition with core rivals absent from this list: Magnet Forensics, Microsystemation, Oxygen Forensics and Exterro.
Cognyte Software Ltd. competes with Cellebrite for government agencies buying software to combine and analyze investigation data. Watch Cognyte’s government-contract revenue for clues to demand for investigative analytics, an area Cellebrite also serves with Pathfinder.
Axon Enterprise competes with Cellebrite for law-enforcement agencies’ evidence-management software spending. Their evidence sources are complementary: Axon’s connected devices capture evidence, while Cellebrite’s tools extract it from phones.
Palantir Technologies competes with Cellebrite’s expanding investigative analytics business and planned Guardian Investigate offering by selling government customers platforms that integrate and analyze data. Watch Palantir’s government business, rather than its commercial business, for the relevant competitive signal.
Open Text Corp competes with Cellebrite for private-sector customers buying tools to collect and examine electronic evidence for corporate investigations. That overlap concerns Cellebrite’s enterprise and service-provider customers, rather than the public-sector customers that supplied more than 90% of its revenue in 2025.
Tyler Technologies and Cellebrite both serve government agencies modernizing police and justice workflows. Agencies buy public-safety and justice software from Tyler and investigative tools from Cellebrite, making that modernization spending the connection to watch.
Tyler Technologies, Inc. earningsTYL
Tyler Technologies’ government business will show whether agencies are still buying software to modernize police and justice workflows, the spending pool Cellebrite also serves.
Look at growth in Tyler Technologies’ government business and whether related sales continue. Strength would suggest agencies are still funding police and justice modernization, supporting the budget environment Cellebrite sells into; weakness or slower sales could signal delayed or tighter agency purchases. Tyler covers broader government software, so its results do not establish that Cellebrite orders moved the same way.
Palantir Technologies Inc. earningsPLTR
Palantir Technologies’ government business will show whether agencies are buying integrated data-analysis platforms, a market where it competes with Cellebrite’s investigative analytics.
Focus on Palantir Technologies’ government revenue and sales momentum, not its commercial business. Strength would show agencies are still buying integrated data-analysis tools, a supportive demand backdrop for Cellebrite’s investigative analytics; weakness could signal slower purchasing, but Palantir’s results alone cannot show whether Cellebrite won or lost sales.
Axon Enterprise, Inc. earningsAXON
Axon Enterprise’s report will show whether police are buying evidence-management software, the spending category where it competes with Cellebrite.
Look for Axon Enterprise’s evidence-management software sales or related business performance, not just sales of connected devices. Strong software results would show police are still funding tools to manage digital evidence; weakness could point to tighter budgets in that category, a tougher setting for Cellebrite to win evidence-management spending. Their evidence sources differ, so Axon does not directly measure demand for Cellebrite’s phone-extraction tools.
Cellebrite DI Ltd. earningsThis company
Cellebrite gets most of its revenue from government subscriptions, and this report will show whether agencies keep renewing and adding tools.
Read subscription-revenue growth alongside the dollar-based net retention rate, which tracks added subscriptions from existing customers. If both hold up, government agencies are renewing and buying more; slower growth with lower retention points to weaker renewals or expansion. Because government agencies provide most revenue and much subscription revenue is recognized over the contract term, current revenue can keep growing even as new business softens; the key is whether new and renewed contracts replace that business.
